Site Search
Professionals 531 results
Capabilities 84 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies.
Experience 484 results
Experience
|September 23, 2025
Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals
Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).
Experience
|September 11, 2025
$1.5 Billion Raymond James Financial, Inc. Public Offering of Senior Notes
We served as underwriters' counsel to BofA Securities, Citigroup, J.P. Morgan and Raymond James, as joint book-running managers, in connection with the registered public offering of $1.5 billion of Senior Notes by Raymond James Financial, Inc. comprised of $650 million of its 4.900% Senior Notes due 2035, and $850 million of its 5.650% Senior Notes due 2055.
Experience
|September 9, 2025
Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms.
Insights & News 7,219 results
Sponsorship
|October 22, 2025
Winston & Strawn Sponsors the 2025 Eastern District of Texas Bench Bar Conference
Winston & Strawn is a proud sponsor of the 2025 Eastern District of Texas Bench Bar Conference, one of the nation’s top annual bench bar conferences. The conference brings together judges, lawyers, topic speakers, guests, and other participants from across the world to discuss a broad range of cutting-edge legal topics.
Webinar
|October 21, 2025
Bayes H1 2025 UK Debt Market Survey Results
UK CRE market: surprising results for a time of macro-economic unpredictability, and fiscal and trade policy volatility.
Sponsorship
|October 19, 2025
Winston & Strawn Sponsors The 2025 National Summit for Middle Market Funds
Winston & Strawn is proud to be an elite sponsor of The 2025 National Summit for Middle Market Funds, the premier event for lower middle market networking and fundraising.
Other Results 78 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Law Glossary
Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product.
Site Content
Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies.